Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer

References

• Li S, Xu HX, Wu CT, et al. Angiogenesis in pancreatic cancer: current research status and clinical implications. Angiogenesis. 2019;22(1):15–36.
   PubMed Web of Science ®Google Scholar
• Huang X, Ding L, Liu X, et al. Regulation of tumor microenvironment for pancreatic cancer therapy. Biomaterials. 2021;270:120680.
   PubMed Web of Science ®Google Scholar
• Cheng J, Lou Y, Jiang K. Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b/ARF1 axis. Bioengineered. 2021;12(1):96–107.
   PubMed Web of Science ®Google Scholar
• Abbassi R, Algül H. Palliative chemotherapy in pancreatic cancer-treatment sequences. Transl Gastroenterol Hepatol. 2019;4:56.
   PubMed Web of Science ®Google Scholar
• Kleeff J, Michalski C, Friess H, et al. Pancreatic cancer - From bench to 5-year survival. Pancreas. 2006;33(2):111–118.
   PubMed Web of Science ®Google Scholar
• Perkhofer L, Ettrich TJ, Seufferlein T. Pancreatic Cancer: progress in Systemic Therapy. Gastrointest Tumors. 2015;1(4):167–179.
   Web of Science ®Google Scholar
• Bornschein J. A new horizon in the primary diagnosis of pancreatic cancer. Z Gastroenterol. 2020;58(7):693–694.
   PubMedGoogle Scholar
• Buscail L, Bournet B, Cordelier P. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2020;17(3):153–168.
   PubMed Web of Science ®Google Scholar
• Wolpin BM, Hezel AF, Abrams T, et al. Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer. J Clin Oncol. 2009;27(2):193–198.
   PubMed Web of Science ®Google Scholar
• Yu G, Jia B, Cheng Y, et al. MicroRNA-429 sensitizes pancreatic cancer cells to gemcitabine through regulation of PDCD4. Am J Transl Res. 2017;9(11):5048–5055.
   PubMed Web of Science ®Google Scholar
• Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–1825.
   PubMed Web of Science ®Google Scholar
• Deyme L, Barbolosi D, Gattacceca F. Population pharmacokinetics of FOLFIRINOX: a review of studies and parameters. Cancer Chemother Pharmacol. 2019;83(1):27–42.
   PubMed Web of Science ®Google Scholar
• Welch SA, Moore MJ. Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancer. Future Oncol. 2007;3(3):247–254.
   PubMedGoogle Scholar
• Wood AK, Sehgal CM. A review of low-intensity ultrasound for cancer therapy. Ultrasound Med Biol. 2015;41(4):905–928.
   PubMed Web of Science ®Google Scholar
• Shi J, Fu C, Su X, et al. Ultrasound-Stimulated Microbubbles Inhibit Aggressive Phenotypes and Promotes Radiosensitivity of esophageal squamous cell carcinoma. Bioengineered. 2021;12(1):3000–3013.
   PubMed Web of Science ®Google Scholar
• Shen Z, Shao J, Zhang J, et al. Ultrasound cavitation enhanced chemotherapy: in vivo research and clinical application. Exp Biol Med (Maywood). 2020;245(14):1200–1212.
   PubMed Web of Science ®Google Scholar
• Kang ST, Yeh CK. Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future design. Chang Gung Med J. 2012;35(2):125–139.
   PubMedGoogle Scholar
• Izzo F, Granata V, Grassi R, et al. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: an Update. Oncologist. 2019;24(10):e990–e1005.
   PubMed Web of Science ®Google Scholar
• Xuan W, Yan Y, Wan M, et al. Antitumor activity of mHSP65-TTL enhanced by administration of low dose cyclophosphamide in pancreatic cancer-bearing mice. Int Immunopharmacol. 2015;27(1):95–103.
   PubMed Web of Science ®Google Scholar
• Faustino-Rocha A, Oliveira PA, Pinho-Oliveira J, et al. Estimation of rat mammary tumor volume using caliper and ultrasonography measurements. Lab Anim. 2013;42(6):217–224.
   PubMed Web of Science ®Google Scholar
• Abrams SL, Kvin L, Yang LV, et al. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals. Adv Biol Regul. 2018;69:16–34.
   PubMedGoogle Scholar
• Fang Y, Zhou W, Rong Y, et al. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer. Exp Cell Res. 2019;383(1):111543.
   PubMed Web of Science ®Google Scholar
• Oura S, Tamaki T, Hirai I, et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer. 2007;14(1):48–54.
   PubMedGoogle Scholar
• Yu Y, Bai W, Chen Y, et al. Low-frequency and low-intensity ultrasound-mediated microvessel disruption enhance the effects of radiofrequency ablation on prostate cancer xenografts in nude mice. Mol Med Rep. 2015;12(5):1218–1219.
   Web of Science ®Google Scholar
• Xu WP, Shen E, Bai WK, et al. Enhanced antitumor effects of low-frequency ultrasound and microbubbles in combination with simvastatin by downregulating caveolin-1 in prostatic DU145 cells. Oncol Lett. 2014;7(6):2142–2148.
   PubMed Web of Science ®Google Scholar
• Sheng L, Zhang S, Xu H. Effect of Slug-Mediated Down-Regulation of E-Cadherin on Invasiveness and Metastasis of Anaplastic Thyroid Cancer Cells. Med Sci Monit. 2017;23:138–143.
   PubMed Web of Science ®Google Scholar
• Sharili AS, Allen S, Smith K, et al. Snail2 promotes osteosarcoma cell motility through remodelling of the actin cytoskeleton and regulates tumor development. Cancer Lett. 2013;333(2):170–179.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang H, Zhu J, et al. Mollugin induces tumor cell apoptosis and autophagy via the PI3K/AKT/mTOR/p70S6K and ERK signaling pathways. Biochem Biophys Res Commun. 2014;450(1):247–254.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Jang B. The Role of Autophagy in Hepatocellular Carcinoma. Int J Mol Sci. 2015;16(11):26629–26643.
   PubMed Web of Science ®Google Scholar
• Westphal S, Kalthoff H. Apoptosis: targets in pancreatic cancer. Mol Cancer. 2003;2:6.
   PubMedGoogle Scholar
• Murphy KM, Ranganathan V, Farnsworth ML, et al. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ. 2000;7(1):102–111.
   PubMed Web of Science ®Google Scholar
• Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3(8):917–921.
   PubMed Web of Science ®Google Scholar
• Li YJ, Wei ZM, Meng YX, et al. β-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis. World J Gastroenterol. 2005;11(14):2117–2123.
   PubMed Web of Science ®Google Scholar
• Huang S, Sinicrope FA. Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells. Autophagy. 2010;6(2):256–269.
   PubMed Web of Science ®Google Scholar
• Qiu DM, Wang GL, Chen L, et al. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance. BMC Cancer. 2014;14:327.
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282(33):24131–24145.
   PubMed Web of Science ®Google Scholar
• Diakopoulos N, Gorgulu K, Stevanovic M, et al. Levels of Atg5 determine pancreatic tumor formation and metastasis in mice. Pancreatology. 2018;18.
   Google Scholar
• Morselli E, Galluzzi L, Kepp O, et al. Anti- and pro-tumor functions of autophagy. BBA - Mol Cell Res. 2009;1793(9):1524–1532.
   PubMed Web of Science ®Google Scholar